drugset / Trial / NCT05408247

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder

NCT05408247

Phase 4 Recruiting 280 enrolled University of Sydney Monash University · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To explore the effectiveness of n-acetylcysteine in improving treatment outcomes for alcohol use disorder in a double-blind randomised placebo-controlled trial.

Timeline

Start
2023-02-16
Primary completion
2025-11
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1200 mg Oral